Pathophysiological Study of the Sensitive Scalp

NCT ID: NCT07156422

Last Updated: 2025-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sensitive skin is defined as a syndrome manifested by the occurrence of unpleasant sensations (tingling, burning, pain, pins and needles) in response to stimuli that should not normally cause them. These unpleasant sensations cannot be explained by lesions attributable to a specific skin disease. Sensitive skin can affect different parts of the body. The scalp is a site that is often affected, with specificity linked in particular to the presence of hair and different triggering factors (styling habits, wearing of head coverings, application of cosmetics to the scalp, etc.). Sensitive scalp affects around half the population, and can have an impact on the quality of life of sufferers, particularly those whose symptoms are very intense. Women are more likely than men to have a sensitive scalp, so in order to have a more homogenous study population, we chose to include 40 women. The pathophysiology of sensitive skin is imperfectly understood, and studies specific to the sensitive scalp are very rare. However, the pathophysiology of the sensitive scalp could be different because it is a hairy area, more innervated, and less exposed to environmental factors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Each patiente will have a sample taken in the dermatology department:

* 1 skin biopsy of the scalp (non-routine medical procedure)
* Completion of questionnaires

40 adult women
* 20 women with a sensitive scalp (cases)
* 20 women without a sensitive scalp (controls)

Patientes with the sensitive scalp will be recruited from the dermatology department. There will be no further visits, so the duration of the study is 1 day.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sensitive Scalp

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

case-control study
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Histological and innervation analyses will be carried out in a blinded fashion.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case group (patient with sensitive scalp)

A 'sensitive scalp' group, with an overall 3S score ≥3 and a pruritus sub-score ≥2. As pruritus is widely described as the main symptom of sensitive scalp, recruitment will be based on the presence of pruritus.

Group Type OTHER

A scalp biopsy using a 4 mm punch in the retroauricular hair zone

Intervention Type PROCEDURE

a scalp biopsy using a 4 mm punch in the retroauricular hair zone under local anesthesia

a general health questionnaire

Intervention Type OTHER

a general health questionnaire : demographics, history, treatment, smoking, alcohol consumption, phototype.

Questionnaires concerning their sensitive scalp

Intervention Type OTHER

* The characteristics of a sensitive scalp (location, chronicity, triggering and soothing factors, use of cosmetics, etc.)
* Sensitive Scalp Score (3S)
* Impact on quality of life: BoSS questionnaire
* Impact of pruritus on quality of life (ItchyQol)

Control group (patient with "normal" scalp)

\- A 'non-sensitive scalp' group, with a 3S score of 0.

Group Type OTHER

A scalp biopsy using a 4 mm punch in the retroauricular hair zone

Intervention Type PROCEDURE

a scalp biopsy using a 4 mm punch in the retroauricular hair zone under local anesthesia

a general health questionnaire

Intervention Type OTHER

a general health questionnaire : demographics, history, treatment, smoking, alcohol consumption, phototype.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A scalp biopsy using a 4 mm punch in the retroauricular hair zone

a scalp biopsy using a 4 mm punch in the retroauricular hair zone under local anesthesia

Intervention Type PROCEDURE

a general health questionnaire

a general health questionnaire : demographics, history, treatment, smoking, alcohol consumption, phototype.

Intervention Type OTHER

Questionnaires concerning their sensitive scalp

* The characteristics of a sensitive scalp (location, chronicity, triggering and soothing factors, use of cosmetics, etc.)
* Sensitive Scalp Score (3S)
* Impact on quality of life: BoSS questionnaire
* Impact of pruritus on quality of life (ItchyQol)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult women without dermatosis
* Collection of free and informed consent
* patient affiliated to a social security scheme

For the control group: Sensiscalp score = 0/20 Sensitive scalp group: Sensiscalp score ≥ 3/20 with pruritus sensation ≥ 2/20

Exclusion Criteria

* Refusal to take part in the study
* Dermatosis of the scalp (psoriasis, seborrhoeic dermatitis, etc.)
* Pregnant and breast-feeding women
* Women under legal protection (guardianship, curatorship)
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Brest

Brest, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emilie BRENAUT, Dr

Role: CONTACT

2 98 22 35 90 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emilie BRENAUT, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

29BRC24.0318 - SENSISCALP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Swiss Itch Registry
NCT06120907 RECRUITING
Study to Evaluate the Safety of Colchicine
NCT05335148 RECRUITING PHASE1